Pilot Study: Endoscopic-assisted Plasma Radiofrequency Ablation: A Minimally Invasive Strategy for Extremity Lymphatic Malformations

初步研究:内镜辅助等离子射频消融术:一种治疗肢体淋巴管畸形的微创策略

阅读:1

Abstract

BACKGROUND: Lymphatic malformations (LMs) of the extremities present a therapeutic challenge due to their diffuse infiltration of subcutaneous and deep fascial compartments, often complicated by previous treatment failures and high recurrence rates. METHODS: We conducted a pilot study to evaluate the feasibility and safety of a novel minimally invasive technique, endoscopic-assisted plasma radiofrequency ablation (EPRA), in managing complex extremity LMs. Between November 2024 and April 2025, 5 patients with recurrent, multilayered LMs involving the thigh, knee, or calf underwent EPRA under general anesthesia. Magnetic resonance imaging and multidisciplinary evaluation confirmed preoperative diagnosis and lesion mapping. The procedure used small incisions for endoscopic access, continuous saline irrigation for hydrodissection, and bipolar radiofrequency ablation to selectively coagulate aberrant lymphatic vessels under direct visualization. RESULTS: All cases were completed without conversion to open surgery, with a mean operative time of 60 minutes. No major complications were observed, and transient postoperative edema resolved spontaneously within 1 week. At short-term follow-up, patients demonstrated functional preservation and satisfactory cosmetic outcomes, with no evidence of early recurrence. CONCLUSIONS: The EPRA technique offers a promising therapeutic alternative that combines the precision of endoscopy with the targeted energy delivery of radiofrequency ablation, thereby minimizing collateral damage and reducing the risks associated with conventional sclerotherapy or open resection. This initial experience supports the feasibility and safety of EPRA for extremity LMs, particularly in anatomically complex or treatment-refractory cases, and provides a foundation for future studies with expanded patient cohorts and long-term outcomes.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。